As people age, they suffer from a variety of health disorders. With the advancement in age, different degenerative and oxidative processes cause degeneration of various parts of the eye including the macula. Age-related macular degeneration (AMD or ARMD), is a medical condition that results in the loss of central vision due to the degeneration of the retina, particularly in the macular area. AMD is now the most common cause of irreversible vision loss in the western world.

MacuZohm^® Sublispray^® was made to strengthen the macular health as most eye supplement ingredients do not reach the target areas when consumed via tablets. A long trial was done with the Vitonnix^® MacuZohm^® Sublispray^® and amazing results were found.

Summary of Trial:

Abstract

Objective: Examining the effect of a nutritional supplement (Vitonnix^® macular sublingual spray) on human eye health.

Study Design & Participants: The double-blind placebo-controlled study was conducted. Group A suffering from early or intermediate age-related macular degeneration and Group B, not affected with age-related macular degeneration.

All the 60 subjects were over 50 years of age. Patients with bilateral advanced AMD or any other pre-existing eye conditions were excluded from the study. The participants of each of the A and B groups were equally divided into test and placebo subgroups.

Methods: Vitonnix^® macular sublingual spray was administered to the test groups. The placebo groups received a vitamin D sublingual spray. Effect of Vitonnix^® macular spray-on contrast sensitivity, visual acuity and visual performance in the participants was assessed.

Results: After six month’s study period, there was an improvement in people who were on the MacuZohm^® spray in terms of their mean contrast sensitivity, visual acuity and visual performance. There was no significant change in the scores of the placebo groups.

The study was a huge leap forward and Vitonnix^® is committed to the constant and never-ending improvement of each of its products.